Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients

• Ivana Grbesa ,

  Contributed equally to this work with: Ivana Grbesa, María J. Pajares

  Affiliations Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain, Group for Translational Medicine, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia

  ⨯
• María J. Pajares ,

  Contributed equally to this work with: Ivana Grbesa, María J. Pajares

  * E-mail: mpajares@unav.es

  Affiliations Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain, Department of Histology and Pathology, School of Medicine, University of Navarra, 31008 Pamplona, Spain, Navarra’s Health Research Institute (IDISNA), Pamplona, Spain

  ⨯
• Elena Martínez-Terroba,

  Affiliations Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain, Department of Histology and Pathology, School of Medicine, University of Navarra, 31008 Pamplona, Spain

  ⨯
• Jackeline Agorreta,

  Affiliations Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain, Department of Histology and Pathology, School of Medicine, University of Navarra, 31008 Pamplona, Spain, Navarra’s Health Research Institute (IDISNA), Pamplona, Spain

  ⨯
• Ana-Matea Mikecin,

  Affiliation Laboratory of Experimental Therapy, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia

  ⨯
• Marta Larráyoz,

  Affiliation Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain

  ⨯
• Miguel A. Idoate,

  Affiliations Navarra’s Health Research Institute (IDISNA), Pamplona, Spain, Department of Pathology, University Hospital and Faculty of Medicine, University of Navarra, 31008 Pamplona, Spain

  ⨯
• Koraljka Gall-Troselj,

  Affiliation Laboratory of Epigenomics, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia

  ⨯
• Ruben Pio,

  Affiliations Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain, Navarra’s Health Research Institute (IDISNA), Pamplona, Spain, Department of Biochemistry and Genetics, School of Science, University of Navarra, 31008 Pamplona, Spain

  ⨯
• Luis M. Montuenga

  Affiliations Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain, Department of Histology and Pathology, School of Medicine, University of Navarra, 31008 Pamplona, Spain, Navarra’s Health Research Institute (IDISNA), Pamplona, Spain

  ⨯